A Study to Test Whether ZS (Sodium Zirconium Cyclosilicate) Can Reduce the Incidence of Increased Blood Potassium Levels Among Dialized Patients.
Public ClinicalTrials.gov record NCT03303521. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3b, Multicenter, Prospective, Randomized, Double Blind, Placebocontrolled Study to Reduce Incidence of Pre-dialysis Hyperkalemia With Sodium Zirconium Cyclosilicate (DIALIZE)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy of ZS in the treatment of hyperkalemia in patients on hemodialysis.
Study identification
- NCT ID
- NCT03303521
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 196 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 130 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 14, 2017 (Actual)
- Primary completion
- Nov 7, 2018 (Actual)
- Completion
- Nov 7, 2018 (Actual)
- Last update posted
- Feb 20, 2020
2017 – 2018
United States locations
- U.S. sites
- 15
- U.S. states
- 6
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Los Angeles | California | 90022 | — |
| Research Site | Los Angeles | California | 90025 | — |
| Research Site | Ontario | California | 91762 | — |
| Research Site | San Dimas | California | 91773 | — |
| Research Site | Whittier | California | 90606 | — |
| Research Site | Kansas City | Missouri | 64108 | — |
| Research Site | St Louis | Missouri | 63110 | — |
| Research Site | Paterson | New Jersey | 07504 | — |
| Research Site | Fresh Meadows | New York | 11365 | — |
| Research Site | Great Neck | New York | 11021 | — |
| Research Site | Ridgewood | New York | 11385 | — |
| Research Site | The Bronx | New York | 10461 | — |
| Research Site | East Providence | Rhode Island | 02914 | — |
| Research Site | El Paso | Texas | 79924 | — |
| Research Site | Houston | Texas | 77004 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03303521, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 20, 2020 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03303521 live on ClinicalTrials.gov.